BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 11168352)

  • 1. Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come?
    Radin NS
    Eur J Biochem; 2001 Jan; 268(2):193-204. PubMed ID: 11168352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
    Kartal Yandım M; Apohan E; Baran Y
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting ceramide metabolism--a strategy for overcoming drug resistance.
    Senchenkov A; Litvak DA; Cabot MC
    J Natl Cancer Inst; 2001 Mar; 93(5):347-57. PubMed ID: 11238696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
    Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
    Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer treatment strategies targeting sphingolipid metabolism.
    Oskouian B; Saba JD
    Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
    Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
    Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
    Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
    Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting.
    Cuvillier O; Ader I; Bouquerel P; Brizuela L; Malavaud B; Mazerolles C; Rischmann P
    Curr Mol Pharmacol; 2010 Jun; 3(2):53-65. PubMed ID: 20302564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bioactive sphingolipids in physiology and pathology.
    Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
    Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of autophagy by sphingolipids.
    Bedia C; Levade T; Codogno P
    Anticancer Agents Med Chem; 2011 Nov; 11(9):844-53. PubMed ID: 21707487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of short-chain ceramide and glucosylceramide on sphingolipids and protein kinase C.
    Abe A; Wu D; Shayman JA; Radin NS
    Eur J Biochem; 1992 Dec; 210(3):765-73. PubMed ID: 1483461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killing tumours by ceramide-induced apoptosis: a critique of available drugs.
    Radin NS
    Biochem J; 2003 Apr; 371(Pt 2):243-56. PubMed ID: 12558497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells.
    Bassoy EY; Baran Y
    Biomed Pharmacother; 2012 Mar; 66(2):103-10. PubMed ID: 22326625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.
    Kartal M; Saydam G; Sahin F; Baran Y
    Nutr Cancer; 2011; 63(4):637-44. PubMed ID: 21500096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of ceramide and complex sphingolipids in neuronal cell function.
    Buccoliero R; Futerman AH
    Pharmacol Res; 2003 May; 47(5):409-19. PubMed ID: 12676515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria and ceramide: intertwined roles in regulation of apoptosis.
    Birbes H; El Bawab S; Obeid LM; Hannun YA
    Adv Enzyme Regul; 2002; 42():113-29. PubMed ID: 12123710
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
    Tabuchi K; Hara A
    Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.
    Van Brocklyn JR; Williams JB
    Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):26-36. PubMed ID: 22613819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.